These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 2527742

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Down syndrome clinical symptoms are manifested in transfected cells and transgenic mice overexpressing the human Cu/Zn-superoxide dismutase gene.
    Groner Y, Elroy-Stein O, Avraham KB, Yarom R, Schickler M, Knobler H, Rotman G.
    J Physiol (Paris); 1990; 84(1):53-77. PubMed ID: 1972759
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Clinical symptoms of Down syndrome are manifested in transgenic mice overexpressing the human Cu/Zn-superoxide dismutase gene.
    Groner Y, Avraham KB, Schickler M, Yarom R, Knobler H.
    Prog Clin Biol Res; 1990; 360():233-62. PubMed ID: 2147288
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Gene dosage of CuZnSOD and Down's syndrome: diminished prostaglandin synthesis in human trisomy 21, transfected cells and transgenic mice.
    Minc-Golomb D, Knobler H, Groner Y.
    EMBO J; 1991 Aug; 10(8):2119-24. PubMed ID: 1829676
    [Abstract] [Full Text] [Related]

  • 8. Sodium and serotonin uptake into Na+ depleted platelets from Down's syndrome and normal subjects.
    McCoy EE, Enns L.
    Biochem Med; 1978 Dec; 20(3):385-94. PubMed ID: 156542
    [No Abstract] [Full Text] [Related]

  • 9. Decreased calcium content and 45Ca2+ uptake in Down's syndrome blood platelets.
    McCoy EE, Sneddon JM.
    Pediatr Res; 1984 Sep; 18(9):914-6. PubMed ID: 6237304
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Participation of a transmembrane proton gradient in 5-hydroxytryptamine transport by platelet dense granules and dense-granule ghosts.
    Wilkins JA, Salganicoff L.
    Biochem J; 1981 Jul 15; 198(1):113-23. PubMed ID: 6459780
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. 5-Hydroxytryptamine (5-HT) transport in Down's syndrome blood platelets: effect of K+ loading.
    Enns L, McCoy EE, Sneddon JN.
    Biochem Pharmacol; 1983 Jun 01; 32(11):1793-5. PubMed ID: 6223638
    [No Abstract] [Full Text] [Related]

  • 15. Cellular clones and transgenic mice overexpressing copper-zinc superoxide dismutase: models for the study of free radical metabolism and aging.
    Ceballos-Picot I, Nicole A, Sinet PM.
    EXS; 1992 Jun 01; 62():89-98. PubMed ID: 1450608
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Nature of lowered 5-hydroxytryptamine uptake by blood platelets of patients with Down's syndrome.
    Tukiainen E, Tuomisto J, Westermarck T, Kupiainen H.
    Acta Pharmacol Toxicol (Copenh); 1980 Nov 01; 47(5):365-70. PubMed ID: 6457503
    [Abstract] [Full Text] [Related]

  • 20. Thymic abnormalities and enhanced apoptosis of thymocytes and bone marrow cells in transgenic mice overexpressing Cu/Zn-superoxide dismutase: implications for Down syndrome.
    Peled-Kamar M, Lotem J, Okon E, Sachs L, Groner Y.
    EMBO J; 1995 Oct 16; 14(20):4985-93. PubMed ID: 7588627
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.